巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    虛擬市場

    Lantheus Holdings

    LNTH
    64.720
    ▲1.190
    ▲1.87%
    概況消息
    最少15分鐘延遲，股票資訊由第三方資訊供應商提供
    ・Lantheus Holdings - 延遲價格・最後更新於 05/07 12:15
    最高位
    65.190
    最低位
    61.710
    開市價
    --
    前收市價
    63.530
    成交量(千)
    25.90
    成交額(百萬)
    14.23
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    4,442.00
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    73.780 - 22.200
    所有資料不保證絕對正確、完整、或實時，僅作為參考使用。投資涉及風險，過往業績並不代表將來表現，作任何投資決定或交易前，閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Lantheus Holdings
    證券代碼
    LNTH.US
    所屬板塊
    Diagnostics & Research
    公司業務
    Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging used by physicians to progress the clarity of the diagnostic image. Its portfolio of imaging products includes medical radiopharmaceuticals such as DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, and Neurolite. Its revenue is generated from the sales of diagnostic imaging agents to wholesalers, distributors radiopharmacy and directly to hospitals and clinics predominantly in the United States.
    發行量
    68634063
    公司總部
    331 Treble Cove Road
    公司網址
    http://www.lantheus.com
    公司電郵
    ir@lantheus.com
    公司電話
    +1 978 671-8001

    最新發佈

    暫無內容

    關於

    Lantheus Holdings(LNTH.US)所屬的行業板塊為Diagnostics & Research。
    Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging used by physicians to progress the clarity of the diagnostic image. Its portfolio of imaging products includes medical radiopharmaceuticals such as DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, and Neurolite. Its revenue is generated from the sales of diagnostic imaging agents to wholesalers, distributors radiopharmacy and directly to hospitals and clinics predominantly in the United States.
    詳細公司背景可參考: http://www.lantheus.com。